Forbes has an interesting article about the pricing, specifically the impact after the introduction of the competing "Auvi-Q" product.

The second page goes into detail about the rebates and discounts given to pharmacy benefit managers which partially explains the list price increases.

Article: http://www.forbes.com/sites/matthewherper/2016/08/30/the-con...